Sign in

CIK 0001551152

  • Large accelerated filer

AbbVie Inc.

Sign in to watch
Ticker
ABBV
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320375147
Phone
+1 847-932-7900
Business address
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, 60064
  1. 4 Grant or award Director acquired 1,421 shares (grant or award)
  2. 4 Grant or award Director acquired 1,421 shares (grant or award)
  3. 4 Grant or award Director acquired 1,421 shares (grant or award)
  4. 4 Grant or award Director acquired 1,421 shares (grant or award)
  5. 4 Grant or award Director acquired 1,421 shares (grant or award)
  6. 4 Grant or award Director acquired 1,421 shares (grant or award)
  7. 4 Grant or award Director acquired 1,421 shares (grant or award)
  8. 4 Grant or award Director acquired 1,421 shares (grant or award)
  9. 4 Grant or award Director acquired 1,421 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale EVP, Chief Commercial Officer sold 27,690 shares at $159.20 ($4,408,375)
  14. 4 Open-market sale VP, Controller sold 18,628 shares at an average $150.01 ($2,794,301)
  15. 4 Shares withheld for taxes SVP & Pres Global Allerg Aesth gave up 803 shares (to pay taxes)
  16. 4 Shares withheld for taxes SVP & Pres Global Allerg Aesth gave up 810 shares (to pay taxes)
  17. 4 Open-market sale EVP, Chief Strategy Officer sold 25,000 shares at an average $147.29 ($3,682,189)
  18. 4 Shares withheld for taxes SVP & Pres Global Allerg Aesth gave up 2,840 shares (to pay taxes)
  19. 4 Open-market sale EVP, Chief Strategy Officer sold 15,000 shares at an average $148.26 ($2,223,836)
  20. 4 Shares withheld for taxes VP, Controller gave up 7,589 shares (to pay taxes)

Page 13 of 44 · 878 filings